
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
THERIVA BIO. DL-,001 SFY0 US87164U5083 BAW/UFN
© 2024 Xetra Newsboard
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Mo | Theriva Biologics, Inc. - 8-K, Current Report | ||
Mo | Theriva Biologics, Inc.: Theriva Biologics Announces Positive Outcomes from the Second Meeting of the Independent Data Monitoring Committee for VIRAGE, the Company's Phase 2b Clinical Trial of VCN-01 in Combination with Chemotherapy for Metastatic Pancrea | The independent data monitoring committee (IDMC) considered VCN-01 to be well tolerated in metastatic PDAC patients treated with standard-of-care chemotherapy gemcitabine/nab-paclitaxelROCKVILLE, Md.... ► Artikel lesen | |
21.03. | Theriva Biologics, Inc. - S-1/A, General form for registration of securities | ||
19.03. | Theriva Biologics, Inc.: Theriva Biologics to Present at the 2025 NeauxCancer Conference | ROCKVILLE, Md., March 19, 2025 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases... ► Artikel lesen | |
08.03. | Theriva Biologics reduziert Verluste im letzten Quartal |